Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased the frequency and broadened the spectrum of lung toxicity, particularly in patients with cancer. The diagnosis of drug-related pneumonitis (DRP) is usually achieved by excluding other potential known causes. Awar...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 January 2021
|
| In: |
Chest
Year: 2021, Volume: 159, Issue: 3, Pages: 1107-1125 |
| ISSN: | 1931-3543 |
| DOI: | 10.1016/j.chest.2020.11.027 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.chest.2020.11.027 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0012369220353137 
|
| Author Notes: | Takeshi Johkoh, MD, PhD; Kyung Soo Lee, MD, PhD; Mizuki Nishino, MD, MPH; William D. Travis, MD; Jay H. Ryu, MD; Ho Yun Lee, MD, PhD; Christopher J. Ryerson, MD, MAS; Tomás Franquet, MD, PhD; Alexander A. Bankier, MD, PhD; Kevin K. Brown, MD; Jin Mo Goo, MD, PhD; Hans-Ulrich Kauczor, MD; David A. Lynch, MB; Andrew G. Nicholson, MD; Luca Richeldi, MD, PhD; Cornelia M. Schaefer-Prokop, MD, PhD; Johny Verschakelen, MD, PhD; Suhail Raoof, MD; Geoffrey D. Rubin, MD, MBA; Charles Powell, MD; Yoshikazu Inoue, MD, PhD; and Hiroto Hatabu, MD, PhD |
Search Result 1